Cases & Deals

Baxter Ventures invests in True North Therapeutics

Clients Baxter International Inc.

Jones Day represented Baxter Ventures in connection with its purchase of Series A Preferred Stock in a private placement by True North Therapeutics, Inc., a biotechnology company that develops treatments for rare diseases. Co-investors included Kleiner Perkins Caufield & Byers, MPM Capital, SR One, and Biogen Idec New Ventures.